Recent Bills
- H.R. 10171August 27, 2026
- H.R. 10156August 27, 2026
- H.R. 10172August 27, 2026
- H.R. 10160August 27, 2026
- H.R. 10181August 27, 2026
- H.R. 10176August 27, 2026
- H.Res. 1496August 27, 2026
- H.R. 10164August 27, 2026
- H.R. 10170August 27, 2026
- H.Res. 1494August 27, 2026
- H.R. 10163August 27, 2026
- H.R. 10157August 27, 2026
Committees
- Administration
- Agriculture
- Agriculture, Nutrition, And Forestry
- Appropriations
- Armed Services
- Banking, Housing, And Urban Affairs
- Budget
- Commerce, Science, And Transportation
- Education and Workforce
- Energy And Commerce
- Energy And Natural Resources
- Environment And Public Works
- Ethics
- Finance
- Financial Services
- Foreign Affairs
- Foreign Relations
- Health, Education, Labor, And Pensions
- Homeland Security
- Homeland Security And Governmental Affa…
- Indian Affairs
- Indian and Insular Affairs
- Intelligence
- Judiciary
- Natural Resources
- Oversight And Government Reform
- Permanent Select Intelligence
- Rules
- Rules And Administration
- Science, Space, And Technology
- Select Intelligence
- Small Business
- Small Business And Entrepreneurship
- Subcommittee on Aviation
- Subcommittee on Border Security and Enf…
- Subcommittee on Coast Guard and Maritim…
- Subcommittee on Commodity Markets, Digi…
- Subcommittee on Conservation, Research,…
- Subcommittee on Counterterrorism and In…
- Subcommittee on Cybersecurity and Infra…
- Subcommittee on Disability Assistance a…
- Subcommittee on Economic Development, P…
- Subcommittee on Economic Opportunity
- Subcommittee on Emergency Management an…
- Subcommittee on Energy and Mineral Reso…
- Subcommittee on Federal Lands
- Subcommittee on Forestry and Horticultu…
- Subcommittee on General Farm Commoditie…
- Subcommittee on Health
- Subcommittee on Highways and Transit
- Subcommittee on Livestock, Dairy, and P…
- Subcommittee on Nutrition and Foreign A…
- Subcommittee on Oversight and Investiga…
- Subcommittee on Oversight, Investigatio…
- Subcommittee on Railroads, Pipelines, a…
- Subcommittee on Transportation and Mari…
- Subcommittee on Water Resources and Env…
- Subcommittee on Water, Wildlife and Fis…
- Transportation And Infrastructure
- Veterans' Affairs
- Ways And Means
MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMERLY MCKESSON CORP) is a registrant on 16 federal lobbying filings, 2023 to 2026.
An LDA filing reports one registrant’s income from one client for everything they worked that quarter, so a total here is the sum of whole filings and never a price for one issue or one bill.
Clients
1 who it filed for, by filings.
| Client | Filings | Reported |
|---|---|---|
| MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS | 16 | — |
By year
Filings and what they reported, newest year first.
| Year | Filings | Income | Expenses |
|---|---|---|---|
| 2026 | 2 | — | $1.4M |
| 2025 | 5 | — | $4.6M |
| 2024 | 4 | — | $3.4M |
| 2023 | 5 | — | $3.4M |
Issues
The LDA issue codes the filings were filed under.
| Code | Issue | Filings |
|---|---|---|
HCR | Health Issues | 16 |
MMM | Medicare/Medicaid | 16 |
PHA | Pharmacy | 16 |
TAX | Taxation/Internal Revenue Code | 11 |
TAR | Tariff (miscellaneous tariff bills) | 10 |
MAN | Manufacturing | 5 |
Bills
The bills the filings name, by how many name them.
| Bill | Title | Filings |
|---|---|---|
| H.R. 2484 | Seniors’ Access to Critical Medications Act of 2025 | 7 |
| H.R. 1 | An act to provide for reconciliation pursuant to title II of H. Con. Res. 14. | 5 |
| H.R. 2120 | ROCR Value Based Program Act | 5 |
| H.R. 2444 | Promoting Resilient Supply Chains Act of 2025 | 5 |
| H.R. 3164 | Ensuring Community Access to Pharmacist Services Act | 5 |
| H.R. 3514 | Improving Seniors’ Timely Access to Care Act of 2025 | 5 |
| H.R. 3521 | Clinical Trial Modernization Act | 5 |
| H.R. 879 | Medicare Patient Access and Practice Stabilization Act of 2025 | 5 |
| S. 1816 | Improving Seniors’ Timely Access to Care Act of 2025 | 5 |
| S. 257 | Promoting Resilient Supply Chains Act of 2025 | 5 |
| H.R. 4299 | Protecting Patient Access to Cancer and Complex Therapies Act | 4 |
| H.R. 2474 | Expanding Appalachia’s Broadband Access Act | 2 |
| H.R. 2630 | Youth Suicide Prevention Research Act | 2 |
| H.R. 3173 | Federal Reserve Financial Accountability and Transparency Act | 2 |
| H.R. 3561 | FORCE Act | 2 |
| H.R. 4011 | Community Paramedicine Act of 2025 | 2 |
| H.R. 4473 | BIRD Health Act of 2025 | 2 |
| H.R. 5376 | Impacts and Outcomes for Health Career Training Act | 2 |
| S. 127 | Whole-Home Repairs Act of 2025 | 2 |
| S. 1339 | Stop CCP Money Laundering Act of 2025 | 2 |
| S. 3018 | A bill to permit visiting dignitaries and service members from Taiwan to display the flag of the Republic of… | 2 |
| S. 3822 | Break Up Big Medicine Act | 2 |
| S. 652 | Protecting Patients from Deceptive Drug Ads Act | 2 |
Lobbyists
Named on the filings.
| Lobbyist | Clients | Filings |
|---|---|---|
| BEN JONES | 1 | 16 |
| JASEY CARDENAS | 1 | 16 |
| JOSHUA BABB | 1 | 16 |
| RICHARD BUCKLEY | 1 | 10 |
| MATTHEW WILLIAMS | 1 | 9 |
| LISA LANGENDERFER | 1 | 8 |
| BRIAN BRANTON | 1 | 7 |
| DAMON PORTER | 1 | 7 |
| DIANA FELNER | 1 | 7 |
| JENNIFER WAGNER | 1 | 5 |
| JOHN RICHARDSON | 1 | 5 |
| PETER SLONE | 1 | 4 |
| KRISTEN BALLANTINE | 1 | 2 |
Filings
The documents themselves, on the Senate’s Lobbying Disclosure site, newest first.
| Client | Registrant | Period | Reported | Posted |
|---|---|---|---|---|
| MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS | MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMERLY MCKESSON CORP) | 2026 second_quarter | $530K | Jul 20, 2026 |
| MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS | MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMERLY MCKESSON CORP) | 2026 first_quarter | $860K | Apr 20, 2026 |
| MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS | MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMERLY MCKESSON CORP) | 2025 fourth_quarter | $1.2M | Jan 19, 2026 |
| MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS | MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMERLY MCKESSON CORP) | 2025 third_quarter | $530K | Oct 20, 2025 |
| MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS | MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMERLY MCKESSON CORP) | 2025 second_quarter | $460K | Jul 17, 2025 |
| MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS | MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMERLY MCKESSON CORP) | 2025 first_quarter | $1.2M | Apr 24, 2025 |
| MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS | MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMERLY MCKESSON CORP) | 2025 first_quarter | $1.2M | Apr 21, 2025 |
| MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS | MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMERLY MCKESSON CORP) | 2024 fourth_quarter | $560K | Jan 21, 2025 |
| MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS | MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMERLY MCKESSON CORP) | 2024 third_quarter | $640K | Oct 17, 2024 |
| MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS | MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMERLY MCKESSON CORP) | 2024 second_quarter | $650K | Jul 19, 2024 |
| MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS | MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMERLY MCKESSON CORP) | 2024 first_quarter | $1.6M | Apr 17, 2024 |
| MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS | MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMERLY MCKESSON CORP) | 2023 fourth_quarter | $720K | Jan 21, 2024 |
| MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS | MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMERLY MCKESSON CORP) | 2023 third_quarter | $530K | Oct 20, 2023 |
| MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS | MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMERLY MCKESSON CORP) | 2023 first_quarter | $1.2M | Aug 9, 2023 |
| MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS | MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMERLY MCKESSON CORP) | 2023 second_quarter | $510K | Jul 20, 2023 |
| MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS | MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMERLY MCKESSON CORP) | 2023 first_quarter | $440K | Apr 20, 2023 |